论文部分内容阅读
在国内建立5～10家销售额50亿元、40家销售额20亿元的大企业集团,使这些企业的销售额占到全国医药市场的7％左右。这一步,是否不再遥远?
In the country to establish 5 to 10 sales of 5 billion yuan, 40 sales of 2 billion yuan in large enterprise groups, so that sales of these companies accounted for about 7% of the national pharmaceutical market. Is this step no longer distant?